Boryung Pharmaceutical Co., Ltd

This study is testing an experimental drug called BR101801 for people with peripheral T-cell lymphoma that has returned or hasn't responded to standard treatments. The trial will enroll 44 participants to see how well the drug shrinks tumors and how safe it is. Patients will take…

This study aims to find the best dose of a new drug, called BR1400, to lower high blood pressure. It will involve 330 adults with high blood pressure who will try one of five different doses or a placebo for 8 weeks. The main goal is to see how much each dose lowers blood pressur…

This early-stage study aims to understand how the body absorbs and processes two common blood pressure medications, fimasartan and indapamide. It will compare taking them as separate pills versus a single combined pill. The study involves 48 healthy volunteers and focuses on safe…

This is an early safety study to see how the body absorbs and processes two common blood pressure medications—fimasartan and indapamide—when given as separate pills versus a single combined pill. It will involve 58 healthy adult volunteers who will take the drugs on an empty stom…

This early-stage study aims to understand how the body processes two blood pressure drugs, given separately and together, in healthy volunteers. It will measure drug levels in the blood and check for safety. The goal is to gather basic information to help design future studies fo…

This early-stage study aims to understand how the body processes and tolerates a new combination pill for high blood pressure. It will involve 48 healthy adult volunteers who will take the pill after a meal. The main goal is to measure the drug levels in the blood and check for s…